Press release
Anti-Hypertensive Drugs Market Size, Share and Forecast 2020-2026
Request a Free Sample of our Anti-Hypertensive Drugs Market: https://www.omrglobal.com/request-sample/anti-hypertensive-drugs-market
However, the high cost associated with anti-hypertensive drugs will turn out to be a major restraint for the growth of the anti-hypertensive market, as it has to be given to the patient for a longer period. Additionally, the low awareness and less diagnosis rate in the developing countries will also hamper the growth of the anti-hypertensive drugs market during the forecast period. Moreover, the side effects of anti-hypertensive drugs such as calcium channel blockers used during pregnancy include tachycardia, palpitations, peripheral edema, headaches, and facial flushing, which will lower the adoption of these drugs. Hence, the low adoption rate of anti-hypertensive drugs during pregnancy will majorly restrict the growth of the anti-hypertensive drug market during the forecast period.
A full Report of Anti-Hypertensive Drugs Market is Available at: https://www.omrglobal.com/industry-reports/anti-hypertensive-drugs-market
Global Antihypertensive Drugs Market Segmentation
By Drug Class
Thiazide Diuretics
Calcium Channel Blockers
ACE Inhibitors
Angiotensin II Receptor Antagonists (ARBS)
Beta Blockers
Others
Regional Analysis
North America
United States
Canada
Europe
UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Company Profiles
AstraZeneca PLC
Bayer AG
Boehringer Ingelheim International GmbH
Daiichi Sankyo Co., Ltd.
Johnson & Johnson Services, Inc.
Lupin Ltd.
Merck KGaA
Noden Pharma DAC
Novartis International AG
Pfizer Inc.
Ranbaxy Laboratories Ltd.
Renata Ltd.
Sanofi S.A.
Sun Pharmaceuticals LLC
Takeda Pharmaceutical Company Ltd.
Teva Pharmaceutical Industries Ltd.
Unichem Laboratories Ltd.
United Therapeutics Corp.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/anti-hypertensive-drugs-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Hypertensive Drugs Market Size, Share and Forecast 2020-2026 here
News-ID: 2205419 • Views: …
More Releases from Orion Market Research Pvt. Ltd.
New Study: Global Scaffold Free 3D Cell Culture Plate Market 2021 Size, Growth A …
The global 3D cell culture market size is expected to reach USD 1846 million in 2024 from USD 882 million in 2019, with a CAGR of 15%. The growth of this market is mainly driven by growing interest in developing alternatives to animal testing, increasing interest in personalized medicines, increasing incidence of chronic diseases and funding research. On the other hand, lack of infrastructure for 3D cell-based research and high…
Antimicrobial Medical Textiles Market Share 2021: Global Trends, Key Players, In …
The global Antibacterial Medical Textiles market size was estimated at USD 422.3 million in 2015 and is projected to register a CAGR of 7% during the forecast period. A growing geriatric population, technological advancements, and regulations facilitating the use of antibacterial fibers are expected to drive the market growth.
High demand in the wound care market, which consists of non-implantable products and products such as health care and hygiene products, can…
DC Power Supplies Market to 2027, Future Outlook, COVID-19 Impact Analysis, Fore …
The global DC power supplies market size is projected to reach USD 454 million by 2024 from an estimated value of USD 361 million in 2019, at a CAGR of 4.7% during the forecast period. The growth of the market is attributed to the growing wireless communication & infrastructure and aerospace & defense segment in countries such as US & Canada and growing demand for industrial automation and consumer electronics…
Global Modified Atmosphere Packaging Market Growth, Size, Share, Industry Report …
The global modified atmosphere packaging market is projected to grow at a CAGR of around 5% during the forecast period. High barrier substrates, such as polyethylene, polyamide, oriented polyethylene terephthalate, ethylene vinyl alcohol, and others are used for modified atmosphere packaging. The three main gases used in modified atmosphere packaging are nitrogen, oxygen, carbon dioxide. The choice of gas depends on the food product being packed. These gases are commonly…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
